ABBOTT LABORATORIES (ABT) › Operating Cash FlowABBOTT LABORATORIES (ABT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: $8.97B2012: $9.31B2013: $3.32B2014: $3.67B2015: $2.97B2016: $3.20B2017: $5.57B2018: $6.30B2019: $6.14B2020: $7.90B2021: $10.53B2022: $9.58B2023: $7.26B2024: $8.56B2025: $9.57B$9.57B2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$9.57B+11.8%2024$8.56B+17.9%2023$7.26B-24.2%2022$9.58B-9.0%2021$10.53B+33.3%2020$7.90B+28.8%2019$6.14B-2.6%2018$6.30B+13.1%2017$5.57B+73.9%2016$3.20B+8.0%2015$2.97B-19.3%2014$3.67B+10.6%2013$3.32B-64.3%2012$9.31B+3.8%2011$8.97B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share